Clinical Trials

    Showing 1 - 10 of 11 Heart Failure

    Status: Open Not Enrolling

    Investigator: Dipan Shah

    Study Coordinator: Fareeha Dadabhoy

    Phone: 713.441.2116

    This study is designed to evaluate the efficacy of Dotarem enhanced MRI compared to Magnevist and Gadavist enhanced MRI in identifying myocardial infarct. Eighty patients will be recruited for this study. Patients with known CAD and undergoing clinic... Read more >

    Status: Open Not Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    Brief Summary: To evaluate safety and effectiveness of the ACURATE Transfemoral Aortic Valve System for transcatheter aortic valve replacement (TAVR) in subjects with severe native aortic stenosis who are indicated for TAVR. Detailed Description: ... Read more >

    Status: Enrolling

    Investigator: Marvin Atkins

    Study Coordinator: Padmaja Naik

    Phone: 713.441.7386

    The purpose of this study is to characterize the safety and effectiveness of the Medtronic Avalus Ultra aortic valve bioprosthesis in patients with aortic valve disease.... Read more >

    Status: Enrolling

    Investigator: Sachin Goel

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    Brief Summary: The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral regurgitation = Grade III in whom transcatheter therapy is dee... Read more >

    Status: Enrolling

    Investigator: Sachin Goel

    Study Coordinator: Tia McGaughy

    Phone: 346.238.4576

    The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, severe native aortic stenosis who are considered intermediate or low ri... Read more >

    Status: Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Deena Victor

    Phone: 713.441.4536

    Brief Summary: Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, symptomatic AS. Detailed Description: Multi-center, international, prospective, randomized study... Read more >

    Status: Open Not Enrolling

    Investigator: Sherif Nagueh

    Study Coordinator: Alharith Humadi

    Phone: 346.238.4551

    Hypertrophic cardiomyopathy (HCM) is the most common monogenic heart disease and the most frequent cause of sudden cardiac death (SCD) in the young. It is characterized by unexplained left ventricular hypertrophy (LVH), diffuse and patchy fibrosis, a... Read more >

    Status: Enrolling

    Investigator: Neal Kleiman

    Study Coordinator: Padmaja Naik

    Phone: 713.441.7386

    The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart proced... Read more >

    Status: Enrolling

    Investigator: Alpesh Shah

    Study Coordinator: Padmaja Naik

    Phone: 713.441.7386

    The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in subjects treated with renal denervation. Additionally, long-term follow-up data will also be colle... Read more >

    Status: Open Not Enrolling

    Investigator: Maham Rahimi

    Study Coordinator: Sohaib Mhaidi

    Phone: 346.238.6402

    This is a multi-surgeon monocentric study at Houston Methodist Hospital (HMH) to decrease the number of groin wound complications using BIASURGE Advanced Surgical Solution (BIASURGE) after common femoral artery exposure for vascular surgery procedure... Read more >

    Status: Enrolling

    Investigator: Sachin Goel

    Study Coordinator: Tia McGaughy

    Phone: 346.238.4576

    Brief Summary: The objective of this early feasibility study is to gain early clinical insight into the performance of the Intrepid transcatheter tricuspid valve replacement (TTVR) system intended for transfemoral access to deliver a self-expanding ... Read more >